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RNAi is proving to be a powerful experimental tool for the
functional annotation of mammalian genomes. The full potential
of this technology will be realized through development of ap-
proaches permitting regulated manipulation of endogenous gene
expression with coordinated reexpression of exogenous trans-
genes. We describe the development of a lentiviral vector plat-
form, pSLIK (single lentivector for inducible knockdown), which
permits tetracycline-regulated expression of microRNA-like short
hairpin RNAs from a single viral infection of any naı¨ve cell system.
In mouse embryonic fibroblasts, the pSLIK platform was used to
conditionally deplete the expression of the heterotrimeric G pro-
teins G12 and G13 both singly and in combination, demonstrat-
ing the G13 dependence of serum response element-mediated
transcription. In RAW264.7 macrophages, regulated knockdown of
G2 correlated with a reduced Ca2 response to C5a. Insertion of
a GFP transgene upstream of the G2 microRNA-like short hairpin
RNA allowed concomitant reexpression of a heterologous mRNA
during tetracycline-dependent target gene knockdown, signifi-
cantly enhancing the experimental applicability of the pSLIK
system.
G protein  tetracycline
The discovery of the RNAi pathway in mammalian cells heraldeda new era in the analysis of mammalian gene function (1, 2). The
sequence specificity of RNAi permits inhibition of endogenous
gene expression by introduction of gene-specific dsRNA into cells.
Stable expression of such dsRNA in the form of a short hairpin
RNA (shRNA) expressed from an RNA polymerase (pol) III
promoter is a useful and widely used approach for the application
of RNAi (3–5). However, long-term suppression using pol III
shRNAs can be problematic (6), and options for conditional
expression are limited. For RNAi-based gene therapy applications,
an ideal platform would constitute a regulatable shRNA exhibiting
high efficacy when expressed at single copy in the genome.
The design of shRNA transcripts as primary microRNA (miR)
mimics (miR-shRNAs) driven by pol II promoters significantly
expands the possibilities for conditional RNAi in mammalian cells
(7–9). Accordingly, tetracycline (Tet)-inducible expression of miR-
shRNAs has recently been described (10, 11), but these studies
either were limited to cell systems with constitutive expression of
the Tet-transactivating components or required cumbersome mul-
tivirus infection. The development of a flexible single vector
configuration for regulatable knockdown of endogenous genes with
miR-shRNAs, combined with reexpression of a transgene, would
provide a valuable experimental tool, with wide applicability in
mammalian cell systems.
In this study we describe the development of a flexible lentiviral
vector platform supporting constitutive expression of a Tet-
transactivating component with a selection marker and coordinated
conditional expression of miR-shRNA(s) targeting single or mul-
tiple gene products. We also demonstrate an additional powerful
feature of this system by combining miR-shRNA and cDNA
expression from the conditional promoter, which increases the
flexibility of this system for functional genomic and gene therapy
applications.
Results
Characterization of Single Lentiviral Vectors Expressing All of the
Required Components for Tet-Regulated pol II Promoter-Driven RNAi.
Self-inactivating lentivirus has been established as an efficient
vehicle for introducing exogenous expression cassettes into a wide
range of cell lines, primary cells, and transgenic animals (10, 12–19)
and has become the favored approach for stable expression of
shRNAs in intractable cells (12–15). We hypothesized that pack-
aging of all of the necessary components for Tet-regulated expres-
sion of miR-shRNAs in a lentiviral vector would permit robust
drug-inducible RNAi in mammalian cells transduced at single copy.
To increase the flexibility of such a system, we adopted a recom-
bination-based cloning strategy that would permit preliminary
identification of potent miR-shRNAs for genes of interest in a
gateway entry vector, such that validated sequences could be easily
shuttled to multiple viral expression platforms (Fig. 1a). We used
the previously described approach of embedding gene-specific
shRNAs in the primary transcript of human miR30 (7, 9), and we
devised a simplified cloning strategy to create miR-shRNA entry
clones (Fig. 5 a and b, which is published as supporting information
on the PNAS web site). Potent miR-shRNAs were identified for the
heterotrimeric G proteins G12 and G13 (Fig. 5d) and subcloned
to lentiviral vectors containing all of the required components for
Tet-ON and Tet-OFF conditional expression with constitutive
coexpression of the fluorescent protein Venus (Fig. 6, which is
published as supporting information on the PNAS web site). We
infected a mouse embryonic fibroblast (MEF) cell line with the
Tet-ON and Tet-OFF lentiviruses at low copy [multiplicity of
infection (MOI) 1], and, after selection of Venus-expressing cells
by FACS, miR-shRNA expression was induced by doxycycline
(DOX) withdrawal (Tet-OFF) or addition (Tet-ON). We observed
relatively poor induction of G12 and G13 knockdown with the
Tet-OFF system, but the Tet-ON vectors gave extremely potent
conditional knockdown of the endogenous G proteins (Fig. 6). The
superior performance of the Tet-ON vector may be attributed to
our use of a third-generation version of the reverse Tet transacti-
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vator (rtTA) (S12G F86Y A209T rtTA3), which has been shown
to have improved DOX sensitivity and activity (20, 21). We named
this vector system pSLIK (single lentivector for inducible knock-
down) and created versions with alternative markers named pSLIK-
Venus and pSLIK-Neo (Fig. 1a).
We noted an interesting property of pSLIK-Venus transduced
cells where the fluorescence intensity of Venus increased 10-fold in
response to DOX (Fig. 1c). We hypothesized that this increase
could be attributed to additional expression of Venus from the
DOX-induced transcript (Fig. 1b). To test this hypothesis, we
assessed the DOX-dependent expression of both rtTA3 and neo-
mycin (Neo) mRNA by quantitative RT-PCR from cells transduced
with a pSLIK-Neo lentivirus, and we observed 10-fold increases
in mRNA levels of both transcripts in the presence of DOX (Fig.
1d). We propose that the addition of DOX initiates a positive
feedback loop where rtTA3 can increase its own expression from
the Tet response element (TRE) promoter, which may also induce
higher levels of conditional miR-shRNA expression. Comparable
autoregulatory increase in rtTA expression has been observed
previously (21).
MEF cells infected at MOI1 with a pSLIK-Venus-G12 virus
showed rapid RNAi kinetics, with significant target knockdown
(90%) observed after 2 days of DOX treatment (Fig. 1e).
Knockdown was stable for 1 week, after which knockdown was
readily reversed upon DOX removal (Fig. 1f). Dose–response
analysis showed significant G12 knockdown at 100 ngml DOX
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Fig. 1. Characteristics of the pSLIK single vector system for conditional RNAi. (a) Schematics of the pSLIK-Venus and pSLIK-Neo vector platforms. Validated
miR-shRNAs in the pENTmiRc2 vector are subcloned by site-specific recombination to either pSLIK vector. (b) Schematic showing predicted constitutive (black)
and DOX-induced (green) transcripts from the pSLIK lentivirus. (c) FACS analysis of Venus expression in pSLIK-Venus transduced MEFs in the absence () and
presence () of DOX (1 gml). The presence of DOX induces a 10-fold increase in the Venus mean fluorescence intensity. (d) DOX-dependent increase in rtTA3
and Neo transcript expression in pSLIK-Neo transduced RAW264.7 cells. Neo selection with G418 was withdrawn from cells during DOX induction. mRNA levels
were assessed by quantitative RT-PCR and normalized to the expression level in the absence of DOX (1 gml). (e) Kinetics of conditional G12 knockdown in
MEFs. Western blot analysis of G12 protein levels in pSLIK-Venus-G12 transduced MEFs cultured in the presence of 1 gml DOX for 8 days (DOX addition).
( f) G12 knockdown is readily reversed during continued culture for 8 days in the absence of DOX. (g) DOX dose–response in pSLIK transduced MEFs. Potent G12
target protein knockdown is induced by 100 ngml DOX.
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(Fig. 1g). These data demonstrate that, using the pSLIK lentiviral
vector, we can introduce a tightly regulated miR-shRNA expression
system for conditional knockdown of endogenous mammalian
genes from a single viral infection.
pSLIK Lentivectors Can Mediate the Conditional Knockdown of Mul-
tiple Genes. It has been demonstrated that certain cellular re-
sponses involving the G12 family can be mediated by either
G12 or G13 (22–24). It would therefore be desirable to
develop an approach that would permit conditional knockdown
of both genes simultaneously. Because the Drosha ribonuclease
often processes primary miRs from within a larger transcript
(25) and previous studies have shown that multiple mature miRs
can be produced from a single transcript (7), we hypothesized
that potent miR-shRNAs targeting G12 and G13 (Fig. 2a)
could be expressed in tandem to permit depletion of both targets
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Fig. 2. Multigene knockdown using pSLIK. (a) Specificity of miR-shRNAs against G12 and G13. MEFs transduced with pSLIK lentiviruses expressing G12 and
G13 miR-shRNAs mediate specific knockdown of their target proteins in the presence of DOX (1 gml). (b) Schematic showing creation of pSLIK lentivirus
encoding tandem miR-shRNAs. miR-shRNAs are concatenated in the pENTmiRc2 entry vector by directional cloning (S, SpeI; X, XbaI; P, PstI), then subcloned to
pSLIK-Venus by site-specific recombination. (c–e) Assessment of G12 (c) and G13 (d) mRNA and protein (e) levels in MEF cell lines transduced with control, G12,
G13, and G12 plus G13 miR-shRNA-expressing pSLIK viruses. RNA and protein were harvested from cells cultured in the absence or presence of DOX (1gml)
for 5 days. mRNA levels were assessed by quantitative RT-PCR and normalized to the expression level in untreated control cells. ( f) LPA induced SRE-dependent
transcription in MEF cell lines transduced with control, G12, G13, and G12 plus G13 miR-shRNA-expressing pSLIK viruses. Cells transfected with SRE-Luc and
pCSK-lacZ were stimulated with 5 M LPA for 7 h. Luciferase activity in cell lysates was assessed from cells cultured in the absence or presence of DOX (1 gml)
for 5 days and was normalized to the level of cotransfected -galactosidase.
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simultaneously. We devised a cloning strategy to concatenate
miR-shRNAs targeting different genes in a gateway entry vector
followed by subcloning to pSLIK-Venus (Fig. 2b). MEF cells
were transduced at MOI 1 with pSLIK-Venus lentiviruses
containing miR-shRNAs targeting G12 and G13 both singly
and in combination. Venus-expressing cells were selected by
FACS, and, after DOX treatment for 5 days, G12 and G13
mRNA and protein levels were assessed (Fig. 2 c–e). Although
we observed slightly reduced target knockdown in the cells
expressing the tandem miR-shRNAs, we still achieved signifi-
cant depletion of both G12 and G13 in the pSLIK-Venus-
G1213 cell line.
The serum response element (SRE) in the c-fos promoter
binds to both the serum response factor and the ternary complex
factor. Transcriptional activity of serum response factor induced
by activation of the lysophosphatidic acid (LPA) receptor is
mediated by the small G protein RhoA (24, 26), and LPA-
induced RhoA activation has been proposed to be mediated by
the G12 family (27, 28). Therefore, we investigated the effect
of suppression of G12 and G13 on SRE-dependent transcrip-
tion induced by LPA. The pSLIK-Venus transduced MEFs
described above were transfected with an SRE-luciferase con-
struct, and LPA-induced luciferase expression was compared in
cells with and without DOX treatment. Luciferase induction was
reduced 80% in the cells depleted in G13 alone, whereas the
cells with depletion of both G12 and G13 showed a 45%
decrease in luciferase induction (Fig. 2f ). It seems likely that the
lesser phenotype in the cells expressing miR-shRNAs against
both G12 and G13 may be due to the lower level of knock-
down of G13 in these cells, and the data support the conclusion
derived from studies with a number of receptors (29) that G13
can be primarily responsible for transmitting specific receptor-
mediated activation of serum response factor. The Tet-inducible
knockdown of multiple genes after transduction of cells with a
single pSLIK lentivirus provides an invaluable experimental
platform for analysis of redundancy in signaling gene families.
pSLIK-Mediated Knockdown of Endogenous Signaling Genes in He-
matopoietic Cells and Coupling of Conditional Knockdown with Trans-
gene Expression. In less tractable cell types, such as those of
hematopoietic origin, expression of shRNAs from lentivirus is a
widely used approach to knockdown levels of endogenous genes
(12, 13). Expression of shRNAs as pol III promoter-driven stem
loops remains the most popular methodology in this respect, and we
have used this strategy extensively in studies of signaling in the
murine macrophage cell lines RAW264.7 (www.signaling-
gateway.orgdatafxmquery?typedesc) and J774A.1 (14, 15).
Although we have found this approach to be satisfactory in the
majority of cases, there are certain drawbacks. We find that during
long-term cell culture, and especially after freeze–thaw of cell lines,
target gene knockdown diminishes (R.R., T.R., J.L., and I.D.C.F.,
unpublished observations). Similar effects have been reported by
others in studies of colorectal carcinoma cells (6). Moreover, we
have found that currently available platforms for Tet-regulated
expression from pol III promoters provide unsatisfactory DOX
dose–response and kinetics in RAW cells (L.A.S. and I.D.C.F.,
unpublished observations). To test the applicability of the pSLIK
vector in RAW cells, we generated a potent miR-shRNA against
the heterotrimeric G protein subunit G2 and cloned it into
pSLIK-Neo (Fig. 1a). RAW cells were transduced with lentivirus at
MOI 1, and cells were selected for Neo resistance. Addition of
DOX induced rapid and robust knockdown of G2 after 2 days that
remained stable for 1 week (Fig. 3a), and knockdown was quickly
reversed after DOX removal (Fig. 3b). An important function of
macrophages is their capacity to respond to chemokines such as
complement factor C5a, and this response is mediated by the G
protein-coupled C5a receptor (14, 30). We assessed the effect of
depleting the G2 subunit on the C5a-mediated Ca2 response in
RAW cells, and we found that 2 days after DOX treatment
the response was diminished significantly relative to cells cultured
in the absence of DOX (Fig. 3 c and d). These studies validate the
applicability of the pSLIK system to introduce conditional RNAi in
less tractable cells from a single viral infection and open up the
attractive possibility of stable, robust, and reversible gene depletion
in both primary cells and animal models.
Recent reports suggest that expression of miR-shRNA and
mRNA together in a monocistronic transcript can lead to both
effective processing of the miR-shRNA and translation of protein
from the mRNA (10, 11). To determine whether the pSLIK system
would support conditional expression of a transgene together with
a miR-shRNA, we constructed a pSLIK-Neo lentiviral vector
expressing both GFP and the G2 miR-shRNA from the TRE
promoter (Fig. 4a). RAW cells were infected at MOI1 and, after
selection for a Neo-resistant population, treated with DOX for 9
days. As reported elsewhere (10), the presence of the intervening
GFP sequence between the promoter and the miR-shRNA ap-
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Fig. 3. pSLIK-based conditional knockdown of G2 in RAW264.7 macro-
phages demonstrates G2 selectivity in C5a-mediated Ca2 response. (a)
Western blot analysis of RAW cells transduced with a pSLIK-Neo-G2 lentivi-
rus. (b) Time course of target protein knockdown in response to 1 gml DOX
for 7 days and recovery kinetics through 7 days after DOX removal. (c) Ca2
response profiles in pSLIK-Neo-G2 transduced RAW cells treated with C5a (10
nM). Cells were cultured in the absence or presence of 1gml DOX for 2 days
before assay. (d) Effect of DOX-dependent G2 knockdown on the C5a-
induced Ca2 peak in pSLIK-Neo-G2 transduced RAW cells. Data were aver-
aged from cells induced with 1gml DOX for 2 and 4 days and normalized to
the peak offset in cells cultured in the absence of DOX.
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peared to facilitate slightly more robust target gene knockdown,
with almost complete depletion of G2 throughout the 9 days of
DOX induction, and this was accompanied by robust induction of
GFP expression (Fig. 4b Left). Upon DOX removal, both G2
knockdown and GFP expression were readily reversed (Fig. 4b
Right). These results add significantly to the applicability of the
pSLIK system by demonstrating the capacity for inducible knock-
down of an endogenous target gene with simultaneous reexpression
of a transgene.
Discussion
These data demonstrate a proof of principle for tightly regulated
knockdown of multiple genes from a single infection of naı¨ve
mammalian cells. Previous efforts to combine all of the com-
ponents of a regulated expression system into a single vector
have met with mixed success, suffering from leaky expression
(16) and poor in vivo transgene expression levels (17). Recently,
an elegant study by Aebischer and colleagues (18) used the
promiscuous transcriptional repression activity of the Kruppel-
associated box domain to create a lentiviral vector that could
promote conditional RNAi. Although versatile, their system
does not support constitutive expression of a transduction
marker while shRNA expression is in the repressed state, and the
application of their system in multiple cell types is done at higher
MOI, where multiple viral integration is likely. The high MOI
also raises the possibility that the nonspecific Kruppel-associated
box domain-mediated transcriptional repression could impact
endogenous genes in the vicinity of the viral integration site(s).
The pSLIK system supports constitutive expression of any
transduction marker before induction of miR-shRNA expres-
sion, the Venus fluorescent protein, and Neo drug selection used
in this study can be easily replaced with cell surface markers for
cell sorting. We observe no evidence of leaky expression from
the TRE promoter used in this study, but this does not discount
the possibility that there is a low basal expression of miR-
shRNA, which could be problematic with highly potent shRNA
sequences. Replacement of the TRE promoter in the
pENTmiRc2 entry vector with the TRE-tight promoter could
address this concern. We believe that the rapid kinetics and
potency of knockdown with pSLIK are supported by the nature
of the vector topology, where TRE-driven rtTA3 expression in
the presence of DOX creates a positive feedback loop driving
higher rtTA3 (and presumably miR-shRNA) expression. Our use
of an optimized rtTA3 variant may facilitate this effect (20, 21).
Tissue-specific regulatable RNAi can also be accommodated in
the pSLIK vector design by replacement of the Ubi-c promoter
with a promoter that would restrict expression of the rtTA3 and
marker gene to a particular cell lineage. Finally, the concomitant
reexpression of a transgene, coupled to regulated miR-shRNA
expression (Fig. 4), opens up an exciting possibility for gene
therapy applications, whereby a mutant gene could be essentially
replaced with an RNAi-resistant functional copy. This could
have broad implications for both basic and applied research
programs.
Methods
Plasmid Construction. The U6 promoter and human mir30 sequence
from pSM2 (generously provided by G. Hannon, Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY) was subcloned to the
pENTR1A-Gent entry vector [American Type Culture Collection
no. 10326362 and Alliance for Cell Signaling (AfCS) no.
A84E0EN1AGXG]. A XhoIEcoRI linker was inserted between
the 5 and 3 mir30 sequences to restore the entire mir30 flanking
sequence and to insert two BfuAI sites positioned to cut precisely
at the mir30 junctions (Fig. 5b). The ccdB gene was cloned into a
HindIII site between the BfuAI sites to create pENhUmiRc2.
miR-shRNA sequences were designed by using the RNAi Codex
algorithm (http:katahdin.cshl.org:9331portalscriptsmain2.pl)
and were cloned by linker annealing and ligation into BfuAI cut
pENhUmiRc2 (Fig. 5c). The most potent miR-shRNAs identified
for murine G12, G13, and G2 targeted the sequences GCGA-
CACCATCTTCGACAACAT, CTGGGTGAGTCTGTAAAG-
TATT, and TGCTCATGTATTCCCACGACAA, respectively.
For pENhUmiRc2 vectors carrying effective miR-shRNAs, the
hU6 promoter was excised by SalI digest and replaced with the TRE
minimal promoter. For coupled conditional expression of a GFP
transgene with a miR-shRNA (Fig. 4), the GFP cDNA sequence
was cloned into a unique SacII site between the TRE promoter
and the miR-shRNA sequence. For the lentiviral vectors, GFP
was removed from the pLUG vector (American Type Culture
Collection no. 10326370 and AfCS no. L01GLUG001XA) and
replaced with a linker containing several unique cloning sites.
Cassettes were inserted containing rtTA3IRESVenus and
rtTA3IRESNeo to create pSLIK-Venus and pSLIK-Neo, re-
spectively. The optimized rtTA3 transactivator (rtTA S12G F86Y
A209T) was generously provided by A. Das (University of Am-
sterdam, Amsterdam, The Netherlands). miR-shRNA-expressing
pSLIK lentiviral vectors were generated by gateway recombination
between the TRE-miR-shRNA entry vectors and the pSLIK des-
tination vectors (Fig. 1a).
Consistent with the policy of the AfCS, all of the plasmid
reagents described in this study have been made available to the
research community through the American Type Culture Col-
lection. Specific details are provided at the AfCS plasmid
database (www.signaling-gateway.orgdataplasmid).
Cell Culture and Transfection. HEK293 and HEK293T cells were
maintained in DMEM, 10% FBS, and 2 mM glutamine. MEF
a
b
Fig. 4. Coupling of conditional miR-shRNA and transgene expression from pSLIK in RAW264.7 macrophages. (a) Schematic showing insertion of a GFP transgene
in a pSLIK-Neo lentivirus encoding the G2 miR-shRNA. (b) Western blot analysis demonstrates that conditional GFP expression is tightly correlated with
conditional G2 knockdown. Upon DOX removal, G2 expression is restored. GFP expression is minimal after 2 days and is completely absent after 4 days.
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cells were maintained in DMEM, 10% FBS, 100 unitsml
penicillin, and 100 gml streptomycin. RAW264.7 cells were
maintained in DMEM, 10% FBS, 20 mM Hepes, and 2 mM
glutamine. For miR-shRNA testing, HEK293 cells (5  105)
were seeded into six-well plates the day before transfection and
transfected with 1.5 g of YFP target gene expression plasmid
and 0.5 g of pENhU-miR-shRNA plasmid using Lipo-
fectamine 2000 (Invitrogen, San Diego, CA). Two days after
transfection, knockdown of the YFP-tagged target gene was
assessed by YFP Western blot. For SRE-luciferase assay, MEF
cells (7  104) were seeded into six-well plates the day before
transfection. Cells were transfected with 1 g of SRE-Luc
(Stratagene, San Diego, CA) and 0.1 g of pCsk lac Z plasmid
using Lipofectamine 2000. After starvation for 18 h with DMEM
containing 0.5% FBS, cells were treated with LPA and harvested
for luciferase assays.
Lentivirus Production and Infection. The pSLIK lentivector expres-
sion vector was transfected along with third-generation lentivirus
packaging and pseudotyping plasmids (19) into HEK293T cells
using Lipofectamine 2000 reagent (Invitrogen). HEK293T cells
were cultured in DMEM (GIBCO Invitrogen), 10% FCS (Gem-
ini), and 2 mM glutamine. Plasmids were cotransfected by using
10 g of pSLIK plasmid, 7.5 g of each of the two packaging
plasmids pMDLgpRRE and pRSVREV, and 5 g of the
vesicular stomatitis virus (VSV) G envelope plasmid pVSV
diluted in Opti-MEM (Gibco Invitrogen). The medium was
replaced after 12 h with Ultraculture medium (Cambrex, Balti-
more, MD). The viral supernatant was collected 48 h after
transfection and concentrated by using a Centricon Plus-70 filter
unit (Millipore). Cells were infected at a low MOI to ensure
30% infection frequency such that the majority of transduced
cells contained single viral integrants. Infection frequency was
correlated with Venus expression assessed by FACS.
mRNA and Protein Expression Analysis. Total RNA was isolated from
cells by using RNeasy mini kits (Qiagen), and cDNA was prepared
by using the iScript cDNA synthesis kit (Bio-Rad). Quantitative
RT-PCR was carried out as described (31). Sense and antisense
amplification primers and probe primer sequences were as follows:
G12, 5-GAGGGTTCTTGTGGACGCTC-3, 5-AAACATC-
CCGTGCTTCTCGTT-3, and 5-FAM-CTCGGCATTCCCTG-
GCAGCACTCT-BHQ1–3; G13, 5-ACAAGTTGATG-
GCATTTGATACCC-3, 5-AGGCTCTGATAGCAGGA-
AGATACT-3, and 5-Texas red-TCGAGTCTCCACCATC-
CCCTGGGC-BHQ2–3; G2, 5-ATGCGGGGATTCCA-
CACTGA-3, 5-GGGTCCTCCGTGTTCTCATCT-3, and 5-
FAM-TCGCCCCACTGGGTCCAGCCC-BHQ1–3; -actin
reference, 5-TCCATGAAATAAGTGGTTACAGGA-3, 5-
CAGAAGCAATGCTGTCACCTT-3, and 5-HEX-TCCCT-
CACCCTCCCAAAAGCCACC-BHQ1–3. rtTA3 and Neo
mRNA was quantified by SYBR-Green incorporation using the
following amplification primers: rtTA3, 5-GCGAGTCATG-
GCAAGACTTTC-3 and 5-GAGCTGATTTTCCAGGGTT-
TCG-3; Neo, 5-TGGCTACCCGTGATATTGCTG-3 and 5-
AAGGCGATAGAAGGCGATGC-3. Isolation of cell protein
lysates and Western blotting was carried out as described (31). The
following antisera were used: anti-YFP (BD Clontech, catalog no.
8371-2), anti-G12 (Santa Cruz Biotechnology, catalog no. sc-409),
anti-G13 (Santa Cruz Biotechnology, catalog no. sc-410), and
anti-G2 (Santa Cruz Biotechnology, catalog no. sc-380). Fluores-
cence intensity of Venus was assessed in WT and pSLIK-Venus-
G12 transduced MEFs (10,000 cells) by FACS.
Luciferase Assay. Luciferase assays were performed with a lucif-
erase assay kit (Promega, Madison, WI), and the activity of
cotransfected -gal was measured with a -gal assay kit (Roche,
Palo Alto, CA). Transfection efficiency was corrected by the
ratio of luciferase activity to -gal activity in the same sample.
Measurement of Intracellular Ca2 Mobilization. RAW cells (6 
104) were seeded into 96-well clear-bottomblack-wall plates
(Corning, Frederick, CO) 24 h before assay. Cells were incu-
bated with 4 M fura-2AM in Hanks’ balanced salt solution,
0.5% BSA, and 2.5 mM Probenecid (pH 7.45) (HBP) for 30 min
at room temperature and then washed twice with HBP, and the
volume was replaced after final wash. After 30 min of incubation
at 37°C, Ca2 mobilization in response to 10 nM C5a (Sigma
Aldrich, catalog no. C5788) was assessed by using a FlexStation
(Molecular Devices, Sunnyvale, CA).
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